First Swine Flu Shots Will Not Be Safety Tested: Targeted are Infants, Toddlers, School-age Children, and Pregnant Women

Hmmm...that's exactly what it is...an ASSUMED pandemic, because a pandemic doesn't really exist...YET!! The vaccination itself contains the LIVE (attenuated) virus, which will in essence be the REAL cause of a pandemic...and ENGINEERED PANDEMIC just like the one in 1918 and 1976!!

By Ginger Taylor

On Friday, the National Biodefense Science Board met in emergency session to work on issues surrounding the H1N1 flu pandemic.  They reviewed the report of their working group, "H1N1 COUNTERMEASURES STRATEGY AND DECISION-MAKING:  A REPORT" [HERE], in order to provide input on it before it is sent to the Advisory Committee on Immunization Practices who makes final recommendations to Kathleen Sebelius on what the response to the outbreak should be.

They are working off of several key ASSUMPTIONS:

Novel H1N1 viruses will continue to circulate.
A second wave is likely to occur, as soon as fall 2009. Best estimates suggest that infection rates will be 2‐3 times higher than expected with seasonal influenza. The second wave could peak in October, but we must anticipate onset as early as September.
Attack rates will continue to be highest in children and young adults.
Hospitalizations and deaths will continue to be concentrated among children and younger adults with underlying medical conditions.
Children will continue to act as an amplifier to community spread of the virus.
Severity will continue to be similar to or somewhat greater than the current wave but the number of cases will be substantially larger.
Catastrophic disruption of societal function, as anticipated in some planning scenarios for a severe pandemic, is unlikely.

Waiting for a full characterization of the immunologic properties of candidate vaccines with extensive studies, and doing studies in series would result in the H1N1 vaccine not being available until late fall.
Having vaccine only after the peak may be worse than having no vaccine at all: it incurs all of the risk and cost with no potential benefit. Licensed vaccines, or vaccines similar to licensed products, will be most acceptable at the beginning of the next epidemic wave.
Safety of the vaccines, both real and perceived, will shape risk‐benefit calculations and acceptance. This will be true for both public health officials applying a collective perspective, and for individuals deciding whether to be vaccinated.
Decisions about vaccine formulation must be made rapidly on the basis of available data. Strategies can and should be changed as more data become available, but we cannot wait beyond mid‐August if vaccine is to be in supply by mid‐September.
The Biomedical Advanced Research & Development Authority (BARDA) strategic goal of being able to produce vaccine for all 300 million Americans within 6 months of declaration of a pandemic is an appropriate goal for capacity. However, it is not the same as the strategic goal for dealing with a specific pandemic.

Much of their probable agenda has already been publicly discussed, but here are a list of the board's current stance on vaccine issues. from page 5 of the report:

Goals and Principles:

A critical goal is to have some monovalent novel H1N1 vaccine available by mid‐September 2009, should it be needed. This goal can take advantage of the decades of experience with other H1N1 subunit vaccines, typically at a 15‐mcg dose.
Begin with the goal of targeting a small amount of the vaccine to a small group where it will do the most good. To the extent possible, this should be driven by sound epidemiologic data.
This likely means focusing on infants, toddlers, school‐age children, pregnant women, and adults with risk factors applicable to novel H1N1 virus. Manufacturing of vaccine for additional cohorts of the US population and the world should proceed, but without interfering with the goals listed above.
Safety monitoring must be in place before novel H1N1 vaccination begins, and have the sensitivity, power, and speed to detect signals and determine causal relations in a timely manner to aid policy and communication.
HHS should remind States and local health departments that durable record‐keeping of who receives the vaccine (preferably in electronic format) is an essential component of local implementation plans.
HHS should consider recommending school‐based immunization delivery for children for logistical simplicity.
Decision‐making should remain flexible, based on clearly articulated principles and scientific evidence, and should be transparent.

Of the greatest concern to me was this portion of the paper:

If the United States Government (USG) wants to have novel H1N1 vaccine available in September 2009, it should pursue a simplified testing program to achieve that goal. Additional studies may be appropriate for additional supplies in subsequent months, but time of availability seems to be the dominant criterion for vaccine decision making.
Decades of experience with A/H1N1 influenza viruses provide a basis for selecting initial antigen quantities and dosing. If the US goal is vaccine availability on the shelf in September 2009, 15‐mcg unadjuvanted subunit vaccine and live attenuated intranasal vaccine for children may be a rational approach.
 If the second wave is delayed or production is slower than expected, mix‐and‐match studies of vaccine plus separate adjuvant may yield information that may stretch the available vaccine supply.

During the discussion, it was decided that the board would not only recommend having the first doses of the vaccine ready by September 15th, that they would shoot for September 1.  However since the clinical trials of the vaccines will begin just this week, the studies will not be completed by the time manufacturing decisions must be made in order to meet the September deadline.

So it was decided to recommend that the first few tens of millions of doses be formulated and produced BEFORE the results of the clinical trials are in.  After the trials are completed, they will then have the option to go back and make changes to the vaccine.  It sounded like the second round of vaccine would be expected at the end of October, but they were not completely clear on that.

This means that members of the public who are vaccinated with the H1N1 flu shot in September and likely October will be receiving an untested vaccine.  (Note that these will most likely be children, infants and pregnant women).

This seems contrary to the statement that Kathleen Sebelius made on the "Meet The Press" this week when she said:

"We're on track to have a vaccine ready by mid-October. We need to make sure it's safe, and so clinical trials will begin. And we need to make sure it's, it's effective against this new novel strain. So that's what's happening in the meantime. And if the scientists say it's a go, by mid-October we will have a vaccine available and start with the priority communities."

Scientists are already saying "go" and the people will have no such assurances that it will work, or be safe, when it is first administered.

The National Biodefense Science Board [HERE] will be meeting at least once a month for the next six months as this plan evolves.  By law all meetings must be open to the public, and they are being teleconferenced.  I encourage our community to be listening in and providing public comment and questions.

Ginger Taylor, M.S. is a former marriage and family therapist raising her seven year old son Chandler, who lapsed into autism following his 18 month vaccinations.  She blogs at AdventuresInAutism.com

http://www.ageofautism.com/2009/07/first-swine-flu-shots-will-not-be-safety-tested.html

'Accidental’ Contamination Of Vaccine With Live Avian Flu Virus Virtually Impossible

Czech Papers Question Whether Contaminated Baxter Vaccine Was ‘Attempt to Provoke Pandemic’

Paul Joseph Watson
Prison Planet.com
Thursday, March 5, 2009

Czech newspapers are questioning if the shocking discovery of vaccines contaminated with the deadly avian flu virus which were distributed to 18 countries by the American company Baxter were part of a conspiracy to provoke a pandemic.

The claim holds weight because, according to the very laboratory protocols that are routine for vaccine makers, mixing a live virus biological weapon with vaccine material by accident is virtually impossible.

“The company that released contaminated flu virus material from a plant in Austria confirmed Friday that the experimental product contained live H5N1 avian flu viruses,” reports the Canadian Press.

Baxter flu vaccines contaminated with H5N1 - otherwise known as the human form of avian flu, one of the most deadly biological weapons on earth with a 60% kill rate - were received by labs in the Czech Republic, Germany, and Slovenia.

Initially, Baxter attempted to stonewall questions by invoking “trade secrets” and refused to reveal how the vaccines were contaminated with H5N1. After increased pressure they then claimed that pure H5N1 batches were sent by accident. This was seemingly an attempt to quickly change the story and hide the fact that the accidental contamination of a vaccine with a deadly biological agent like avian flu is virtually impossible and the only way it could have happened was by wilful gross criminal negligence.

According to a compiled translation from Czech newspaper stories, the media over there is asking tough questions about whether the contamination was part of a deliberate attempt to start a pandemic.

“Was this just a criminal negligence or it was an attempt to provoke pandemia using vaccination against flu to spread the disease - as happened with the anti-B hepatitis vaccination with vaccines containing the HIV virus in US? - and then cash for the vaccines against H5N1 which Baxter develops? How could on Earth a virus as H5N1 come to the ordinary flu vaccines? Don’t they follow even basic precautions in the american pharma companies?” states the translation.

The fact that Baxter mixed the deadly H5N1 virus with a mix of H3N2 seasonal flu viruses is the smoking gun. The H5N1 virus on its own has killed hundreds of people, but it is less airborne and more restricted in the ease with which it can spread. However, when combined with seasonal flu viruses, which as everyone knows are super-airborne and easily spread, the effect is a potent, super-airbone, super deadly biological weapon.

As the Canadian Press article explains, “While H5N1 doesn’t easily infect people, H3N2 viruses do. If someone exposed to a mixture of the two had been simultaneously infected with both strains, he or she could have served as an incubator for a hybrid virus able to transmit easily to and among people.”

There can be little doubt therefore that this was a deliberate attempt to weaponize the H5N1 virus to its most potent extreme and distribute it via conventional flu vaccines to the population who would then infect others to a devastating degree as the disease went airborne.

The Canadian Press article states, “That mixing process, called reassortment, is one of two ways pandemic viruses are created,” but then claims that there is no evidence that this is what Baxter were doing, despite there being no clear explanation as to why Baxter has samples of the live avian flu virus on its premises in the first place.

However, to reiterate, the key aspect of this story is that it is virtually impossible for live avian flu virus to find its way into a vaccine by “accident”.

As health expert Mike Adams points out, “The shocking answer is that this couldn’t have been an accident. Why? Because Baxter International adheres to something called BSL3 (Biosafety Level 3) - a set of laboratory safety protocols that prevent the cross-contamination of materials.”

As explained on Wikipedia (http://en.wikipedia.org/wiki/Biosaf…):

“Laboratory personnel have specific training in handling pathogenic and potentially lethal agents, and are supervised by competent scientists who are experienced in working with these agents. This is considered a neutral or warm zone. All procedures involving the manipulation of infectious materials are conducted within biological safety cabinets or other physical containment devices, or by personnel wearing appropriate personal protective clothing and equipment. The laboratory has special engineering and design features.”

Under the BSL3 code of conduct, it is impossible for live avian flu viruses to contaminate production vaccine materials that are shipped out to vendors around the world.

This leaves only two possibilities that explain these events:

Possibility #1: Baxter isn’t following BSL3 safety guidelines or is so sloppy in following them that it can make monumental mistakes that threaten the safety of the entire human race. And if that’s the case, then why are we injecting our children with vaccines made from Baxter’s materials?

Possibility #2: A rogue employee (or an evil plot from the top management) is present at Baxter, whereby live avian flu viruses were intentionally placed into the vaccine materials in the hope that such materials might be injected into humans and set off a global bird flu pandemic.

Spreading bird flu would create an instantaneous surge of demand for bird flu vaccines. The profits that vaccine companies such as Baxter International could reap out of such a panic are astronomical.

In addition, as we have previously reported, those that have a stake in the Tamiflu vaccine include top globalists and BIlderberg members like George Shultz, Lodewijk J.R. de Vink and former Secretary of Defense Donald Rumsfeld.

Authorities in both Europe and the U.S. have openly detailed plans for martial law, quarantine and internment should a bird flu pandemic occur.

The other motivation, as we have exhaustively documented on this website for years, is the fact that elites throughout history have openly stated that they want to see a world population reduction of around 80 per cent. Shocking stories like this take the plausibility of that narrative out of the realms of conspiracy theory and into the dangerous reality of conspiracy fact.

“Baxter is acting a whole lot like a biological terrorism organization these days, sending deadly viral samples around the world. If you mail an envelope full of anthrax to your Senator, you get arrested as a terrorist. So why is Baxter — which mailed samples of a far more deadly viral strain to labs around the world — getting away with saying, essentially, “Oops?”, Adams concludes.

This is not the first time that vaccine companies have been caught distributing vaccines contaminated with deadly viruses.

In 2006 it was revealed that Bayer Corporation had discovered that their injection drug, which was used by hemophiliacs, was contaminated with the HIV virus. Internal documents prove that after they positively knew that the drug was contaminated, they took it off the U.S. market only to dump it on the European, Asian and Latin American markets, knowingly exposing thousands, most of them children, to the live HIV virus. Government officials in France went to prison for allowing the drug to be distributed. The documents show that the FDA colluded with Bayer to cover-up the scandal and allowed the deadly drug to be distributed globally. No Bayer executives ever faced arrest or prosecution in the United States.

Research related articles:

1. Vaccines as Biological Weapons? Live Avian Flu Virus Placed in Baxter Vaccine Materials Sent to 18 Countries
2. Virus mix-up by lab could have resulted in pandemic
3. The Pentagon’s alarming project: Avian Flu Biowar Vaccine
4. URGENT WARNING: H5N1 DNA in Flu Vaccine
5. Universal Vaccine for the Flu? Look No Further Than Vitamin C and Zinc
6. Scientists close in on ‘universal’ vaccine for flu: study
7. The super vaccine that protects you from all types of flu for LIFE
8. Novartis recalls vaccines in contamination scare
9. Smokers should get pneumonia vaccine: U.S. advisers
10. Mystery virus hits 15 million PCs around the world
11. The Alex Jones Show - L I V E - March 5 - The Baxter Bird Flu Scandal
12. Vaccine Court: Autism Debate Continues

Read More:

'This was infected with a bird flu virus.' Viral Pandemic H5N1 flu threat: Illinois-based Baxter contaminates European labs by error 25 Feb 2009 According to the scientific network PROMED, Baxter International Inc. in Austria "unintentionally contaminated samples with the bird flu virus that were used in laboratories in 3 neighboring countries, raising concern about the potential spread of the deadly disease". As PROMED reports, the contamination has been discovered when ferrets at a laboratory in the Czech Republic died after being inoculated with vaccine made from the samples early this month. "The material came from Deerfield, Illinois-based Baxter, which reported the incident to the Austrian Ministry of Health, Sigrid Rosenberger, a ministry spokeswoman, said today in a telephone interview", the network-alert-system is quoting. "This was infected with a bird flu virus," Rosenberger said. "There were some people from the company who handled it."

'That mixing process, called reassortment, is one of two ways pandemic viruses are created.' Baxter admits sending live avian flu viruses to subcontrator --People familiar with biosecurity rules are dismayed by evidence that human H3N2 and avian H5N1 viruses somehow co-mingled [!] in the Orth-Donau facility. 27 Feb 2009 The company that released contaminated flu virus material from a plant in Austria confirmed Friday that the experimental product contained live H5N1 avian flu viruses. And an official of the World Health Organization's European operation said the body is closely monitoring the investigation into the events that took place at Baxter International's research facility in Orth-Donau, Austria.

'Suddenly the ferrets started dying, so the research stopped on Feb. 6.' Czech researchers exposed to bird flu virus via vaccine --Pharmaceutical company that developed vaccine admitted it mistakenly sent infected material to Czech Republic 18 Feb 2009 Thirteen Czech researchers have been exposed to the H5N1 bird flu virus strain through a contaminated vaccine obtained from an Austrian company, Mlada fronta Dnes (MfD) reported Tuesday. The 13 people who had contact with the ferrets were in danger but were not infected with the lethal virus, said Josef Duben, a spokesman for the Czech veterinary authority. The bird flu virus was being tested positive on ferrets by the Biotest company in Konarovice when the animals began to die.

[See: Flu 'Oddities'.]